Currently tested antigens include prostate-specific antigen for prostate cancer (NCT00583752 and NCT00583024), MAGE-A3 for solid tumor, human papilloma virus (HPV) E6/E7 for HPV-associated cancers (NCT02285816, NCT02879760, and NCT03773744), and carcinoembryonic antigen (CEA) for colorectal and pancreatic cancers (NCT03329248 and NCT03387098). The gene discussed is CEACAM5; the disease is cancer.